The Signal Expert insights and opinions on clinical research and drug development. Expert insights and opinions on clinical research and drug development. Category: Scientific Advisory ASCP 2022: Scientific Posters Compilation June 30, 2022 Signant Health Posted in Scientific Advisory Signant’s psychiatry experts and CNS thought leaders presented scientific posters at the American Society of Clinical Psychopharmacology’s 2022 annual meeting… Read More Get to Know the SME: Manuela Bossi May 19, 2022 Signant Health Posted in Scientific Advisory Tell us about your journey to Signant Health. My scientific background is in psychology, and I have years of clinical… Read More Signant Health’s Clinical Scientist Jennifer Olt Receives ISCTM New Investigator Award May 11, 2022 Signant Health Posted in Scientific Advisory Jennifer Olt, Ph.D., a Clinical Scientist from Signant Health’s Operations – Clinical Science team, accepted a 2022 New Investigator Award… Read More 5 Tips for Success in Rare Disease Studies January 14, 2022 Joan Busner Posted in Scientific Advisory Before you begin planning your rare disease study, it’s important to identify potential challenges. At Signant, we believe that the… Read More The Center for Drug Evaluation’s (CDE) draft PRO guidance December 16, 2021 Bill Byrom Posted in eCOA In the landscape of rapidly growing numbers of pharmaceutical clinical trials in China, the Chinese Center for Drug Evaluation (CDE)… Read More Get to Know the SME: Danielle Middleton December 3, 2021 Signant Health Posted in Scientific Advisory We sat down with Signant Health’s newest addition to our in-house team of experts, Dr. Danielle Middleton. Danielle leverages her… Read More CTAD 2021: Scientific Posters Compilation November 17, 2021 Signant Health Posted in Scientific Advisory At the 14th annual Clinical Trials on Alzheimer’s Disease (CTAD) conference, hosted in Boston from November 9-12, 2021, Signant’s renowned… Read More 5 Reasons to Prioritize Rater Training October 29, 2021 Signant Health Posted in Scientific Advisory The quality of assessments is an essential clinical trial component that is often overlooked. In placebo-controlled trials, accurate ratings are… Read More Get to Know the SME: Todd Feaster, PsyD. October 11, 2021 Signant Health Posted in Scientific Advisory In the first of this new series of Q&A interviews with Signant’s subject matter experts, we sat down with Todd… Read More ISCTM Autumn Conference 2021: Poster Presentations Roundup October 5, 2021 Signant Health Posted in Events The International Society for CNS Clinical Trials and Methods (ISCTM) hosted its 2021 Autumn Conference from Sept 30 – October… Read More 1 2 Next
Category: Scientific Advisory ASCP 2022: Scientific Posters Compilation June 30, 2022 Signant Health Posted in Scientific Advisory Signant’s psychiatry experts and CNS thought leaders presented scientific posters at the American Society of Clinical Psychopharmacology’s 2022 annual meeting… Read More Get to Know the SME: Manuela Bossi May 19, 2022 Signant Health Posted in Scientific Advisory Tell us about your journey to Signant Health. My scientific background is in psychology, and I have years of clinical… Read More Signant Health’s Clinical Scientist Jennifer Olt Receives ISCTM New Investigator Award May 11, 2022 Signant Health Posted in Scientific Advisory Jennifer Olt, Ph.D., a Clinical Scientist from Signant Health’s Operations – Clinical Science team, accepted a 2022 New Investigator Award… Read More 5 Tips for Success in Rare Disease Studies January 14, 2022 Joan Busner Posted in Scientific Advisory Before you begin planning your rare disease study, it’s important to identify potential challenges. At Signant, we believe that the… Read More The Center for Drug Evaluation’s (CDE) draft PRO guidance December 16, 2021 Bill Byrom Posted in eCOA In the landscape of rapidly growing numbers of pharmaceutical clinical trials in China, the Chinese Center for Drug Evaluation (CDE)… Read More Get to Know the SME: Danielle Middleton December 3, 2021 Signant Health Posted in Scientific Advisory We sat down with Signant Health’s newest addition to our in-house team of experts, Dr. Danielle Middleton. Danielle leverages her… Read More CTAD 2021: Scientific Posters Compilation November 17, 2021 Signant Health Posted in Scientific Advisory At the 14th annual Clinical Trials on Alzheimer’s Disease (CTAD) conference, hosted in Boston from November 9-12, 2021, Signant’s renowned… Read More 5 Reasons to Prioritize Rater Training October 29, 2021 Signant Health Posted in Scientific Advisory The quality of assessments is an essential clinical trial component that is often overlooked. In placebo-controlled trials, accurate ratings are… Read More Get to Know the SME: Todd Feaster, PsyD. October 11, 2021 Signant Health Posted in Scientific Advisory In the first of this new series of Q&A interviews with Signant’s subject matter experts, we sat down with Todd… Read More ISCTM Autumn Conference 2021: Poster Presentations Roundup October 5, 2021 Signant Health Posted in Events The International Society for CNS Clinical Trials and Methods (ISCTM) hosted its 2021 Autumn Conference from Sept 30 – October… Read More 1 2 Next